Gene · 347
Papers2,410
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,410
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human Plasma Proteome During Normal Pregnancy. | J Proteome Res | 2022 | 36154181 | PubTator, text mining | PubMed |
| Apolipoproteins-New Biomarkers of Overweight and Obesity among Childhood Acute Lymphoblastic Leukemia Survivors? | Int J Mol Sci | 2022 | 36142534 | PubTator, text mining | PubMed |
| Inflammatory and Proliferative Pathway Activation in Human Esophageal Myofibroblasts Treated with Acidic Bile Salts. | Int J Mol Sci | 2022 | 36142285 | PubTator, text mining | PubMed |
| Neurovascular Unit-Derived Extracellular Vesicles: From Their Physiopathological Roles to Their Clinical Applications in Acute Brain Injuries. | Biomedicines | 2022 | 36140248 | PubTator, text mining | PubMed |
| Identification Markers of Carotid Vulnerable Plaques: An Update. | Biomolecules | 2022 | 36139031 | PubTator, text mining | PubMed |
| Application of Micro-Western Array for Identifying Different Serum Protein Expression Profile among Healthy Control, Alzheimer's Disease Patients and Patients' Adult Children. | Brain Sci | 2022 | 36138870 | PubTator, text mining | PubMed |
| Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment. | JCI Insight | 2022 | 36134665 | PubTator, text mining | PubMed |
| Comprehensive analysis of transcriptome characteristics and identification of TLK2 as a potential biomarker in dermatofibrosarcoma protuberans. | Front Genet | 2022 | 36134026 | PubTator, text mining | PubMed |
| Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. | Cardiovasc Diabetol | 2022 | 36131342 | PubTator, text mining | PubMed |
| Single-cell transcriptome reveals cellular hierarchies and guides p-EMT-targeted trial in skull base chordoma. | Cell Discov | 2022 | 36127333 | PubTator, text mining | PubMed |
| Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver disease. | Pharm Biol | 2022 | 36124995 | PubTator, text mining | PubMed |
| Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development. | Front Genet | 2022 | 36118876 | PubTator, text mining | PubMed |
| Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19. | Mayo Clin Proc Innov Qual Outcomes | 2022 | 36117954 | PubTator, text mining | PubMed |
| Oxidative modification of HDL by lipid aldehydes impacts HDL function. | Arch Biochem Biophys | 2022 | 36116503 | PubTator, text mining | PubMed |
| The known unknowns of apolipoprotein glycosylation in health and disease. | iScience | 2022 | 36111253 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals skewed cellular communication and phenotypic shift in pulmonary artery remodeling. | JCI Insight | 2022 | 36099047 | PubTator, text mining | PubMed |
| ATF3 as a potential diagnostic marker of early-stage osteoarthritis and its correlation with immune infiltration through bioinformatics analysis. | Bone Joint Res | 2022 | 36082523 | PubTator, text mining | PubMed |
| Tear Biomarkers in Alzheimer's and Parkinson's Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review). | Int J Mol Sci | 2022 | 36077520 | PubTator, text mining | PubMed |
| The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer. | Int J Mol Sci | 2022 | 36077165 | PubTator, text mining | PubMed |
| The emergence of psychoanalytical electrochemistry: the translation of MDD biomarker discovery to diagnosis with electrochemical sensing. | Transl Psychiatry | 2022 | 36075922 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/347/papers?page=26